Last updated on June 2020

MI 5082-0002 Cohort 3


Brief description of study

ICON Early Phase Services is conducting a research study for healthy adults ages 18-55. This study is being done to test a potential treatment for rare cholestatic liver diseases including Alagille Syndrome (ALGS).  The study drug will be administered orally.

Vital signs, ECGs, physical examinations and pregnancy, drug, alcohol and nicotine  screens will be performed. Blood and urine samples will also be obtained during this study.

Participants will  complete:

  • 1 screening visit
  • 3 consecutive overnights 

To determine if you fully qualify, it will be necessary to obtain blood samples after a  10- hour fast.  You have the option of fasting for the screening appointment, or, you may return at a later date. If ICON does not have your medical records on file, you will need to provide medical records at screening. 

Clinical Study Identifier: TX243683

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.